Tag Archives: Novartis institutes for BioMedical research
September 2018 doi:10.5837/bjc.2018.s11
Cardiovascular research 2018 handbook:
Clinical trials in the UK from a commercial perspective
This article is based on a presentation made by Dr Mark Toms and Dr Tom Thuren
This investment in research also benefits the UK economy providing employment, trade, and addressing shortfalls in STEM skills (Science, Technology, Engineering, and Mathematics). In addition to giving patients faster access to treatments, getting efficacious and safe medicines registered more efficiently enables the trial sponsor to gain reimbursement for those medications sooner. Evolving bio-pharmaceutical model Medical research changed dramatically with the discovery of the structure of DNA and the subsequent understanding of genetic code, with DNA sequencing and amplification. This has led to medicines becoming increasingly personalised
For healthcare professionals only
